Fotofacial/IPL Recovery and Results

The Fotofacial/IPL procedure is a relatively gentle rejuvenation method that involves no downtime, allowing men and women to resume their normal routines immediately following their treatment.

The Fotofacial/IPL technique is a photorejuvenation method, relying on varying light waves to remove damage and restore a healthier, more youthful appearance to damaged skin. Men and women can expect smoother, more even skin tones and texture, as well as a reduction or elimination of blotchy, red skin caused by acne, rosacea, sun damage, hormonal changes, smoking, alcohol and the natural aging process. In addition, the procedure reduces the prominence of facial veins, including tiny broken or otherwise visible capillaries just beneath the skin’s surface.

Most individuals see results immediately after the procedure, with final results becoming evident after any initial redness caused by the procedure subsides. Once your treatment is complete, you may notice slight redness, warmth or even tingling in the treatment area, similar to that which is experienced after a mild sunburn. All of these temporary side effects will disappear within an hour or so of your treatment.

Because the Fotofacial/IPL treatment does not remove skin, like some other cosmetic rejuvenation techniques, recovery is quicker and there are fewer risks than with more invasive procedures. However, like all photorejuvenation procedures, there are some risks to consider when determining whether the Fotofacial/IPL procedure is right for you and your skin type.

Although the Fotofacial/IPL is a gentle, noninvasive facial rejuvenation technique, the risks involved in any photorejuvenation procedure include the possible temporary formation of blisters, scabs, and even bruises, as well as possible changes in skin pigmentation in the areas being treated. Individuals with dark skin may not be considered ideal candidates for this procedure, because it has been linked with hypopigmentation, or loss of skin color, in these men and women.